In humans, the intravenous administration of urate oxidase, replacing the Uox activity lost in hominoid evolution, is used in the enzymatic therapy of severe hyperuricemia and to prevent the burst of uric acid accompanying tumor lysis after certain chemotherapy treatments13. Here, UOX is linked to neoplasm.